References
- Benjamin EJ, Muntner P, Alonso A et al (2019) Heart disease and stroke statistics-2019 update: a report from the American Heart Association. Circulation 139, e56-e528
- Yellon DM and Hausenloy DJ (2007) Myocardial reperfusion injury. N Engl J Med 357, 1121-1135 https://doi.org/10.1056/NEJMra071667
- Staat P, Rioufol G, Piot C et al (2005) Postconditioning the human heart. Circulation 112, 2143-2148 https://doi.org/10.1161/CIRCULATIONAHA.105.558122
- Laskey WK (2005) Brief repetitive balloon occlusions enhance reperfusion during percutaneous coronary intervention for acute myocardial infarction: a pilot study. Catheter Cardiovasc Interv 65, 361-367 https://doi.org/10.1002/ccd.20397
- Hausenloy DJ and Yellon DM (2003) The mitochondrial permeability transition pore: its fundamental role in mediating cell death during ischaemia and reperfusion. J Mol Cell Cardiol 35, 339-341 https://doi.org/10.1016/S0022-2828(03)00043-9
- Beltrami AP, Barlucchi L, Torella D et al (2003) Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114, 763-776 https://doi.org/10.1016/S0092-8674(03)00687-1
- Smith RR, Barile L, Cho HC et al (2007) Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation 115, 896-908 https://doi.org/10.1161/CIRCULATIONAHA.106.655209
- Bergmann O, Bhardwaj RD, Bernard S et al (2009) Evidence for cardiomyocyte renewal in humans. Science 324, 98-102 https://doi.org/10.1126/science.1164680
- Cambria E, Pasqualini FS, Wolint P et al (2017) Translational cardiac stem cell therapy: advancing from first-generation to next-generation cell types. NPJ Regen Med 2, 17 https://doi.org/10.1038/s41536-017-0024-1
- Eschenhagen T, Bolli R, Braun T et al (2017) Cardiomyocyte Regeneration. Circulation 136, 680-686 https://doi.org/10.1161/CIRCULATIONAHA.117.029343
- Li Z, Hu S and Cheng K (2019) Chemical engineering of cell therapy for heart diseases. Acc Chem Res 52, 1687-1696 https://doi.org/10.1021/acs.accounts.9b00137
- Parizadeh SM, Jafarzadeh-Esfehani R, Ghandehari M et al (2019) Stem cell therapy: a novel approach for myocardial infarction. J Cell Physiol 234, 16904-16912 https://doi.org/10.1002/jcp.28381
- Makkar RR, Smith RR, Cheng K et al (2012) Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial. Lancet 379, 895-904 https://doi.org/10.1016/S0140-6736(12)60195-0
- Ostovaneh MR, Makkar RR, Ambale-Venkatesh B et al (2021) Effect of cardiosphere-derived cells on segmental myocardial function after myocardial infarction: ALLSTAR randomised clinical trial. Open Heart 8, e001614 https://doi.org/10.1136/openhrt-2021-001614
- Clifford DM, Fisher SA, Brunskill SJ et al (2012) Stem cell treatment for acute myocardial infarction. Cochrane Data-base Syst Rev 15, Cd006536
- Schachinger V AA, Dobert N, Rover R et al (2008) Pilot trial on determinants of progenitor cell recruitment to the infarcted human myocardium. Circulation 118, 1425-1432 https://doi.org/10.1161/CIRCULATIONAHA.108.777102
- Kaiser J (2018) Suspect science leads to pause in stem cell trial. Science 362, 513 https://doi.org/10.1126/science.362.6414.513
- Bheri S, Hoffman JR, Park HJ and Davis ME (2020) Biomimetic nanovesicle design for cardiac tissue repair. Nanomedicine (Lond) 15, 1873-1896 https://doi.org/10.2217/nnm-2020-0097
- Sluijter JPG, Davidson SM, Boulanger CM et al (2018) Extracellular vesicles in diagnostics and therapy of the ischaemic heart: position paper from the working group on cellular biology of the heart of the European Society of Cardiology. Cardiovasc Res 114, 19-34 https://doi.org/10.1093/cvr/cvx211
- Sahoo S and Losordo DW (2014) Exosomes and cardiac repair after myocardial infarction. Circ Res 114, 333-344 https://doi.org/10.1161/CIRCRESAHA.114.300639
- Bei Y, Das S, Rodosthenous RS et al (2017) Extracellular vesicles in cardiovascular theranostics. Theranostics 7, 4168-4182 https://doi.org/10.7150/thno.21274
- Porto I, Biasucci LM, De Maria GL et al (2012) Intracoronary microparticles and microvascular obstruction in patients with ST elevation myocardial infarction undergoing primary percutaneous intervention. Eur Heart J 33, 2928-2938 https://doi.org/10.1093/eurheartj/ehs065
- Barile L, Moccetti T, Marban E and Vassalli G (2017) Roles of exosomes in cardioprotection. Eur Heart J 38, 1372-1379
- Lin J, Li J, Huang B et al (2015) Exosomes: novel biomarkers for clinical diagnosis. Sci World J 2015, 657086 https://doi.org/10.1155/2015/657086
- Ibrahim A and Marban E (2016) Exosomes: fundamental biology and roles in cardiovascular physiology. Annu Rev Physiol 78, 67-83 https://doi.org/10.1146/annurev-physiol-021115-104929
- Thery C, Amigorena S, Raposo G and Clayton A (2006) Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol Chapter 3, Unit 3.22
- Kowal J, Arras G, Colombo M et al (2016) Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes. Proc Natl Acad Sci U S A 113, E968-E977
- Sodar BW, Kittel A, Paloczi K et al (2016) Low-density lipoprotein mimics blood plasma-derived exosomes and microvesicles during isolation and detection. Sci Rep 6, 24316 https://doi.org/10.1038/srep24316
- Huda MN, Nafiujjaman M, Deaguero IG et al (2021) Potential use of exosomes as diagnostic biomarkers and in targeted drug delivery: progress in clinical and preclinical applications. ACS Biomater Sci Eng 7, 2106-2149 https://doi.org/10.1021/acsbiomaterials.1c00217
- Lotvall J, Hill AF, Hochberg F et al (2014) Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the International Society for Extracellular Vesicles. J Extracell Vesicles 3, 26913 https://doi.org/10.3402/jev.v3.26913
- Ratajczak J, Miekus K, Kucia M et al (2006) Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery. Leukemia 20, 847-856 https://doi.org/10.1038/sj.leu.2404132
- Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ and Lotvall JO (2007) Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9, 654-659 https://doi.org/10.1038/ncb1596
- Marban E (2018) The secret life of exosomes: what bees can teach us about next-generation therapeutics. J Am Coll Cardiol 71, 193-200 https://doi.org/10.1016/j.jacc.2017.11.013
- Choi H, Choi Y, Yim HY, Mirzaaghasi A, Yoo JK and Choi C (2021) Biodistribution of exosomes and engineering strategies for targeted delivery of therapeutic exosomes. Tissue Eng Regen Med 18, 499-511 https://doi.org/10.1007/s13770-021-00361-0
- Lai CP, Mardini O, Ericsson M et al (2014) Dynamic biodistribution of extracellular vesicles in vivo using a multimodal imaging reporter. ACS Nano 8, 483-494 https://doi.org/10.1021/nn404945r
- Smyth T, Kullberg M, Malik N, Smith-Jones P, Graner MW and Anchordoquy TJ (2015) Biodistribution and delivery efficiency of unmodified tumor-derived exosomes. J Control Release 199, 145-155 https://doi.org/10.1016/j.jconrel.2014.12.013
- Lee RH, Kim B, Choi I et al (2004) Characterization and expression analysis of mesenchymal stem cells from human bone marrow and adipose tissue. Cell Physiol Biochem 14, 311-324 https://doi.org/10.1159/000080341
- Lai RC, Chen TS and Lim SK (2011) Mesenchymal stem cell exosome: a novel stem cell-based therapy for cardiovascular disease. Regen Med 6, 481-492 https://doi.org/10.2217/rme.11.35
- Li TS, Cheng K, Malliaras K et al (2012) Direct comparison of different stem cell types and subpopulations reveals superior paracrine potency and myocardial repair efficacy with cardiosphere-derived cells. J Am Coll Cardiol 59, 942-953 https://doi.org/10.1016/j.jacc.2011.11.029
- Lee JW, Lee SH, Youn YJ et al (2014) A randomized, open-label, multicenter trial for the safety and efficacy of adult mesenchymal stem cells after acute myocardial infarction. J Korean Med Sci 29, 23-31 https://doi.org/10.3346/jkms.2014.29.1.23
- Mayourian J, Ceholski DK, Gorski PA et al (2018) Exosomal microRNA-21-5p mediates mesenchymal stem cell paracrine effects on human cardiac tissue contractility. Circ Res 122, 933-944 https://doi.org/10.1161/CIRCRESAHA.118.312420
- Feng Y, Huang W, Wani M, Yu X and Ashraf M (2014) Ischemic preconditioning potentiates the protective effect of stem cells through secretion of exosomes by targeting Mecp2 via miR-22. PLoS One 9, e88685 https://doi.org/10.1371/journal.pone.0088685
- Wang B, Komers R, Carew R et al (2012) Suppression of microRNA-29 expression by TGF-β1 promotes collagen expression and renal fibrosis. J Am Soc Nephrol 23, 252-265 https://doi.org/10.1681/ASN.2011010055
- Park H, Park H, Mun D et al (2018) Extracellular vesicles derived from hypoxic human mesenchymal stem cells attenuate GSK3β expression via miRNA-26a in an ischemia-reperfusion injury model. Yonsei Med J 59, 736-745 https://doi.org/10.3349/ymj.2018.59.6.736
- Messina E, De Angelis L, Frati G et al (2004) Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res 95, 911-921 https://doi.org/10.1161/01.RES.0000147315.71699.51
- Kang IS, Suh J, Lee MN et al (2020) Characterization of human cardiac mesenchymal stromal cells and their extracellular vesicles comparing with human bone marrow derived mesenchymal stem cells. BMB Rep 53, 118-123 https://doi.org/10.5483/bmbrep.2020.53.2.235
- Gray WD, French KM, Ghosh-Choudhary S et al (2015) Identification of therapeutic covariant microRNA clusters in hypoxia-treated cardiac progenitor cell exosomes using systems biology. Circ Res 116, 255-263 https://doi.org/10.1161/CIRCRESAHA.116.304360
- Moghaddam AS, Afshari JT, Esmaeili SA, Saburi E, Joneidi Z and Momtazi-Borojeni AA (2019) Cardioprotective microRNAs: Lessons from stem cell-derived exosomal microRNAs to treat cardiovascular disease. Atherosclerosis 285, 1-9 https://doi.org/10.1016/j.atherosclerosis.2019.03.016
- Takahashi K, Tanabe K, Ohnuki M et al (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861-872 https://doi.org/10.1016/j.cell.2007.11.019
- Yasuda S, Kusakawa S, Kuroda T et al (2018) Tumorigenicity-associated characteristics of human iPS cell lines. PLoS One 13, e0205022 https://doi.org/10.1371/journal.pone.0205022
- Wang Y, Zhang L, Li Y et al (2015) Exosomes/microvesicles from induced pluripotent stem cells deliver cardioprotective miRNAs and prevent cardiomyocyte apoptosis in the ischemic myocardium. Int J Cardiol 192, 61-69 https://doi.org/10.1016/j.ijcard.2015.05.020
- El Harane N, Kervadec A, Bellamy V et al (2018) Acellular therapeutic approach for heart failure: in vitro production of extracellular vesicles from human cardiovascular progenitors. Eur Heart J 39, 1835-1847 https://doi.org/10.1093/eurheartj/ehy012
- Gupta S and Knowlton AA (2007) HSP60 trafficking in adult cardiac myocytes: role of the exosomal pathway. Am J Physiol Heart Circ Physiol 292, H3052-H3056 https://doi.org/10.1152/ajpheart.01355.2006
- de Jong OG, Verhaar MC, Chen Y et al (2012) Cellular stress conditions are reflected in the protein and RNA content of endothelial cell-derived exosomes. J Extracell Vesicles 1, 18396 https://doi.org/10.3402/jev.v1i0.18396
- Heijnen HFG, Schiel AE, Fijnheer R, Geuze HJ and Sixma JJ (1999) Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules. Blood 94, 3791-3799 https://doi.org/10.1182/blood.v94.11.3791.423a22_3791_3799
- Badimon L, Suades R, Fuentes E, Palomo I and Padro T (2016) Role of platelet-derived microvesicles as crosstalk mediators in atherothrombosis and future pharmacology targets: a link between inflammation, atherosclerosis, and thrombosis. Front Pharmacol 7, 293 https://doi.org/10.3389/fphar.2016.00293
- Bouchareychas L, Duong P, Covarrubias S et al (2020) Macrophage exosomes resolve atherosclerosis by regulating hematopoiesis and inflammation via microRNA cargo. Cell Rep 32, 107881 https://doi.org/10.1016/j.celrep.2020.107881
- Oerlemans MI, Mosterd A, Dekker MS et al (2012) Early assessment of acute coronary syndromes in the emergency department: the potential diagnostic value of circulating microRNAs. EMBO Mol Med 4, 1176-1185 https://doi.org/10.1002/emmm.201201749
- Deddens JC, Colijn JM, Oerlemans MI et al (2013) Circulating microRNAs as novel biomarkers for the early diagnosis of acute coronary syndrome. J Cardiovasc Transl Res 6, 884-898 https://doi.org/10.1007/s12265-013-9493-9
- Jansen F, Yang X, Proebsting S et al (2014) MicroRNA expression in circulating microvesicles predicts cardiovascular events in patients with coronary artery disease. J Am Heart Assoc 3, e001249 https://doi.org/10.1161/JAHA.114.001249
- Bi S, Wang C, Jin Y, Lv Z, Xing X and Lu Q (2015) Correlation between serum exosome derived miR-208a and acute coronary syndrome. Int J Clin Exp Med 8, 4275-4280
- Suades R, Padro T, Vilahur G et al (2015) Growing thrombi release increased levels of CD235a(+) microparticles and decreased levels of activated platelet-derived microparticles. Validation in ST-elevation myocardial infarction patients. J Thromb Haemost 13, 1776-1786 https://doi.org/10.1111/jth.13065
- Hafiane A and Daskalopoulou SS (2018) Extracellular vesicles characteristics and emerging roles in atherosclerotic cardiovascular disease. Metabolism 85, 213-222 https://doi.org/10.1016/j.metabol.2018.04.008
- Milasan A, Tessandier N, Tan S, Brisson A, Boilard E and Martel C (2016) Extracellular vesicles are present in mouse lymph and their level differs in atherosclerosis. J Extracell Vesicles 5, 31427 https://doi.org/10.3402/jev.v5.31427
- Jung C, Sorensson P, Saleh N, Arheden H, Ryden L and Pernow J (2012) Circulating endothelial and platelet derived microparticles reflect the size of myocardium at risk in patients with ST-elevation myocardial infarction. Atherosclerosis 221, 226-231 https://doi.org/10.1016/j.atherosclerosis.2011.12.025
- Yin M, Loyer X and Boulanger CM (2015) Extracellular vesicles as new pharmacological targets to treat atherosclerosis. Eur J Pharmacol 763, 90-103 https://doi.org/10.1016/j.ejphar.2015.06.047
- Agouni A, Lagrue-Lak-Hal AH, Ducluzeau PH et al (2008) Endothelial dysfunction caused by circulating microparticles from patients with metabolic syndrome. Am J Pathol 173, 1210-1219 https://doi.org/10.2353/ajpath.2008.080228
- Perrino C, Barabasi AL, Condorelli G et al (2017) Epigenomic and transcriptomic approaches in the post-genomic era: path to novel targets for diagnosis and therapy of the ischaemic heart? position paper of the European Society of Cardiology Working Group on cellular biology of the heart. Cardiovasc Res 113, 725-736 https://doi.org/10.1093/cvr/cvx070
- Suades R, Padro T, Alonso R, Mata P and Badimon L (2013) Lipid-lowering therapy with statins reduces microparticle shedding from endothelium, platelets and inflammatory cells. Thromb Haemost 110, 366-377 https://doi.org/10.1160/TH13-03-0238
- Escudier B, Dorval T, Chaput N et al (2005) Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial. J Transl Med 3, 10 https://doi.org/10.1186/1479-5876-3-10
- Vandergriff AC, de Andrade JB, Tang J et al (2015) Intravenous cardiac stem cell-derived exosomes ameliorate cardiac dysfunction in doxorubicin induced dilated cardiomyopathy. Stem Cells Int 2015, 960926 https://doi.org/10.1155/2015/960926
- Agarwal U, George A, Bhutani S et al (2017) Experimental, systems, and computational approaches to understanding the microrna-mediated reparative potential of cardiac progenitor cell-derived exosomes from pediatric patients. Circ Res 120, 701-712 https://doi.org/10.1161/CIRCRESAHA.116.309935
- Trac D, Hoffman JR, Bheri S, Maxwell JT, Platt MO and Davis ME (2019) Predicting functional responses of progenitor cell exosome potential with computational modeling. Stem Cells Transl Med 8, 1212-1221 https://doi.org/10.1002/sctm.19-0059
- Man K, Brunet MY, Jones MC and Cox SC (2020) Engineered extracellular vesicles: tailored-made nanomaterials for medical applications. Nanomaterials (Basel) 10, 1838 https://doi.org/10.3390/nano10091838
- Armstrong JPK, Holme MN and Stevens MM (2017) Reengineering extracellular vesicles as smart nanoscale therapeutics. ACS Nano 11, 69-83 https://doi.org/10.1021/acsnano.6b07607
- Ostrowski M, Carmo NB, Krumeich S et al (2010) Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat Cell Biol 12, 19-30 https://doi.org/10.1038/ncb2000
- Wang Y, Lu X, He J and Zhao W (2015) Influence of erythropoietin on microvesicles derived from mesenchymal stem cells protecting renal function of chronic kidney disease. Stem Cell Res Ther 6, 100 https://doi.org/10.1186/s13287-015-0095-0
- Palviainen M, Saari H, Karkkainen O et al (2019) Metabolic signature of extracellular vesicles depends on the cell culture conditions. J Extracell Vesicles 8, 1596669 https://doi.org/10.1080/20013078.2019.1596669
- Akuma P, Okagu OD and Udenigwe CC (2019) Naturally occurring exosome vesicles as potential delivery vehicle for bioactive compounds. Front Sustain Food Syst 3, 23 https://doi.org/10.3389/fsufs.2019.00023
- Vandergriff A, Huang K, Shen D et al (2018) Targeting regenerative exosomes to myocardial infarction using cardiac homing peptide. Theranostics 8, 1869-1878 https://doi.org/10.7150/thno.20524
- Li Z, Shen D, Hu S et al (2018) Pretargeting and bioorthogonal click chemistry-mediated endogenous stem cell homing for heart repair. ACS Nano 12, 12193-12200 https://doi.org/10.1021/acsnano.8b05892
- Shen D, Li Z, Hu S et al (2019) Antibody-armed platelets for the regenerative targeting of endogenous stem cells. Nano Lett 19, 1883-1891 https://doi.org/10.1021/acs.nanolett.8b04970
- Mentkowski KI, Snitzer JD, Rusnak S and Lang JK (2018) Therapeutic potential of engineered extracellular vesicles. AAPS J 20, 50 https://doi.org/10.1208/s12248-018-0211-z
- Antes TJ, Middleton RC, Luther KM et al (2018) Targeting extracellular vesicles to injured tissue using membrane cloaking and surface display. J Nanobiotechnology 16, 61 https://doi.org/10.1186/s12951-018-0388-4
- Zhang YN, Poon W, Tavares AJ, McGilvray ID and Chan WCW (2016) Nanoparticle-liver interactions: cellular uptake and hepatobiliary elimination. J Control Release 240, 332- 348 https://doi.org/10.1016/j.jconrel.2016.01.020
- Wu M, Guo H, Liu L, Liu Y and Xie L (2019) Size-dependent cellular uptake and localization profiles of silver nanoparticles. Int J Nanomedicine 14, 4247-4259 https://doi.org/10.2147/IJN.S201107
- Barenholz Y (2012) DoxilⓇ - The first FDA-approved nanodrug: Lessons learned. J Control Release 160, 117-134 https://doi.org/10.1016/j.jconrel.2012.03.020
- Sato YT, Umezaki K, Sawada S et al (2016) Engineering hybrid exosomes by membrane fusion with liposomes. Sci Rep 6, 21933 https://doi.org/10.1038/srep21933
- Moghimi SM, Andersen AJ, Hashemi SH et al (2010) Complement activation cascade triggered by PEG-PL engineered nanomedicines and carbon nanotubes: the challenges ahead. J Control Release 146, 175-181 https://doi.org/10.1016/j.jconrel.2010.04.003
- Wolfram J, Nizzero S, Liu H et al (2017) A chloroquine-induced macrophage-preconditioning strategy for improved nanodelivery. Sci Rep 7, 13738 https://doi.org/10.1038/s41598-017-14221-2
- Wan Z, Zhao L, Lu F et al (2020) Mononuclear phagocyte system blockade improves therapeutic exosome delivery to the myocardium. Theranostics 10, 218-230 https://doi.org/10.7150/thno.38198
- Yong S-B, Song Y, Kim HJ, Ain QU and Kim Y-H (2017) Mononuclear phagocytes as a target, not a barrier, for drug delivery. J Control Release 259, 53-61 https://doi.org/10.1016/j.jconrel.2017.01.024
- Yamada Y, Kobayashi H, Iwasa M et al (2013) Postinfarct active cardiac-targeted delivery of erythropoietin by liposomes with sialyl Lewis X repairs infarcted myocardium in rabbits. Am J Physiol Heart Circ Physiol 304, H1124-H1133 https://doi.org/10.1152/ajpheart.00707.2012
- Liu X, Liu H, Zeng Z, Zhou W, Liu J and He Z (2011) Pharmacokinetics of ligustrazine ethosome patch in rats and anti-myocardial ischemia and anti-ischemic reperfusion injury effect. Int J Nanomedicine 6, 1391-1398
- Su T, Huang K, Ma H et al (2019) Platelet-inspired nanocells for targeted heart repair after ischemia/reperfusion injury. Adv Funct Mater 29, 1803567 https://doi.org/10.1002/adfm.201803567
- Tang J, Shen D, Caranasos TG et al (2017) Therapeutic microparticles functionalized with biomimetic cardiac stem cell membranes and secretome. Nat Commun 8, 13724 https://doi.org/10.1038/ncomms13724
- Liu B, Lee BW, Nakanishi K et al (2018) Cardiac recovery via extended cell-free delivery of extracellular vesicles secreted by cardiomyocytes derived from induced pluripotent stem cells. Nat Biomed Eng 2, 293-303 https://doi.org/10.1038/s41551-018-0229-7